Trials
Search / Trial NCT05652790

Enhanced Rehabilitation After Major Trauma (PROPERLY)

Launched by MANCHESTER UNIVERSITY NHS FOUNDATION TRUST · Dec 7, 2022

Trial Information

Current as of February 05, 2025

Recruiting

Keywords

ClinConnect Summary

The Enhanced Rehabilitation After Major Trauma (PROPERLY) study is looking at how to improve rehabilitation services for patients who have survived serious injuries. The main goal is to see if researchers can successfully invite patients to join the study, keep them involved, and identify any challenges that might come up if they want to do a larger study in the future. Participants in the study will receive at least two sessions a week of a special rehabilitation program designed to help them recover, with each session lasting about 60 to 120 minutes. If someone prefers not to travel for this program or declines to participate, they will be placed in a standard care group where they can still provide feedback through questionnaires and receive their usual therapy.

To be eligible for the study, participants need to be over 18 years old, live in Greater Manchester, and have experienced significant injuries that affect their movement or function. They should also be able to commit to the rehabilitation program for 6 to 30 months after their injury and be willing to travel for their sessions. Participants will be monitored for 12 months, and they need to be able to understand and agree to take part in the study. This trial is important because it aims to identify effective rehabilitation strategies that could help many patients recover better after major trauma.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Participants over 18 years old
  • Registered GP in Greater Manchester or Greater Manchester Resident.
  • Polytrauma or one or more complex /severe isolated injury
  • Rehabilitation goals (e.g., mobility, function, job retention/ return to work) identified using shared decision-making process
  • Patient able to enter programme 6-30 months post injury.
  • For the ERP patients willing to travel to the MIHP for their evaluation and treatment twice a week.
  • Participants with lower limb injuries that continue to have functional impairment.
  • Participants deemed well and safe enough to participate by clinical teams.
  • Normal ECG if previously reported to have abnormal ECG
  • Participants willing to consent to follow up over 12 months
  • Participants with the capacity to consent to the study.
  • Fully healed wounds and bone healed sufficiently to allow at least partial weight bearing
  • Exclusion Criteria:
  • Participants under the age of 18
  • Participants unable to provide informed consent
  • Participants with multiple pre-existing comorbidities that affect ability to participate in enhanced rehabilitation such as cognitive impairment, unstable angina.
  • Central motor neurological impairment affecting ability to participate in an enhanced rehab programme
  • Absence of functional disability affecting gait and / or function.
  • Plans for further surgery that will impact on gait or function.

Trial Officials

Jason Wong, MD

Study Chair

National Health Service, United Kingdom

About Manchester University Nhs Foundation Trust

Manchester University NHS Foundation Trust is a leading healthcare organization dedicated to delivering exceptional patient care and advancing medical research. As an integral part of the UK's National Health Service, the Trust encompasses a range of hospitals and services, fostering innovation in clinical research and trials. With a strong emphasis on collaboration and excellence, Manchester University NHS Foundation Trust is committed to improving health outcomes through rigorous scientific investigation and the translation of research findings into practice, ensuring that patients benefit from the latest advancements in medicine.

Locations

Manchester, Greater Manchester, United Kingdom

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials